Immunotherapy or targeted therapy in BRAF-mutated melanoma: selection of the best therapeutic option and “ex vivo” prospective validation

Carme Solé Blanch

B-ARGO

Date and time: Dimecres, 9 de de juny de 2021 | 09.30

Venue: Online